Duke Chem

What Duke Chem does

Duke Chem S.A.U. is a multipurpose chemical manufacturing plant located in Olérdola, in the Barcelona area of Spain, operating as a single-member public limited company (S.A.U.) within the Gentec Group industrial conglomerate. The company specializes in the research, development, and production of active pharmaceutical ingredients (APIs) and food-grade active principles, serving pharmaceutical and food industry customers across Europe. Its commercial portfolio includes established off-patent APIs such as Brinzolamide USP, Dorzolamide Hydrochloride USP/EP, Etofenamate EP, Febuxostat A and G, Pirisudanol Dimaleate, Nitazoxanide, and Silodosin, plus the nutraceutical L-Carnosine and the excipient Sodium Bitartrate Anhydrous; a development pipeline adds Bepotastine (antihistaminic) and Lifitegrast (Dry Eye Disease). Several products carry USP and EP pharmacopoeia compliance with EDMF and CEP regulatory dossiers.

The underlying technology platform is a multipurpose chemical plant engineered to execute processes in various phases, including distillation and drying, with the capability to run a wide range of chemical reactions. Notable capital assets include a short-path evaporator for distillation optimization — implemented under ERDF co-financed innovation project IDI-20180965 — and a drying plant supported by Spain's Program of Reindustrialization. These assets enable both royalty-free product manufacturing and novel product development under bilateral customer agreements, with confidentiality and discretion positioned as core service guarantees.

The business model is B2B contract manufacturing with quote-based pricing on multi-year engagements; no public pricing is disclosed. The go-to-market is sales-led and direct: customers engage via the company website, phone, or email, supported by a minimal digital presence (website content, Facebook, X, RSS feed). Marketing is relationship-driven rather than scaled, consistent with a small (11–50 employees), enterprise-focused operation. Operating geographies are limited to Europe, with Spain as the anchor market and no global footprint claim.

Name

Duke Chem

Legal name

DUKE CHEM, S.A.U.

Website

https://dukechem.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Duke Chem is a Barcelona-area multipurpose chemical plant (Gentec Group subsidiary) that contract-manufactures active pharmaceutical ingredients and food-grade active principles for European pharmaceutical and food industry clients, offering both royalty-free and custom novel-molecule production.

Ownership category

akta.pro rank

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Infrastructure, Supply Chain, Personnel, Operations, Technology or R&D

Revenue model

1. Active pharmaceutical ingredient manufacturing: Contract manufacturing of active ingredients for pharmaceutical and food industries. Services range from manufacture of royalty-free products to novel products through bilateral agreements with customers.
2. Custom chemical synthesis: Bilateral agreements between Duke Chem and customers for development and manufacture of novel products. Technical equipment and plant facilities provide sophisticated processes adapted to customer needs.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Duke Chem is a multipurpose chemical manufacturing plant that researches, develops, and produces active pharmaceutical ingredients (APIs) and food-grade active principles for the pharmaceutical and food industries. The company manufactures both royalty-free products and novel products through bilateral agreements with customers, leveraging sophisticated chemical processes including optimized distillation (short-path evaporation) and drying capabilities. Its product portfolio spans antiglaucoma, anti-inflammatory, antihyperuricemic, antiparasitic, antihistaminic, and other therapeutic applications, supported by USP, EP, EDMF, and CEP regulatory compliance.

Product overview

Duke Chem S.A.U. is a multipurpose pharmaceutical and food-grade chemical manufacturing plant located in the Barcelona area, operating as part of the Gentec Group. The company produces a portfolio of active pharmaceutical ingredients (APIs) including Brinzolamide USP, Dorzolamide Hydrochloride USP/EP, Etofenamate EP, Febuxostat A/G, Pirisudanol Dimaleate, Nitazoxanide, Silodosin, and L-Carnosine, along with excipients such as Sodium Bitartrate Anhydrous. Additionally, the company maintains a development pipeline with products like Bepotastine (antihistaminic) and Lifitegrast (for Dry Eye Disease). Services include royalty-free product manufacturing, novel product development through bilateral agreements, sophisticated chemical processes, and distillation optimization using short-path evaporation technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Brinzolamide USP Antiglaucoma active pharmaceutical ingredient manufactured for pharmaceutical companies, with EDMF regulatory data, meeting USP standards.
• Dorzolamide Hydrochloride USP/EP Active pharmaceutical ingredient for antiglaucoma treatments, meeting both USP and EP standards with EDMF regulatory compliance.
• Etofenamate EP Anti-inflammatory active pharmaceutical ingredient with EDMF and CEP regulatory compliance, meeting EP standards.
• Febuxostat A Antihyperuricemic active pharmaceutical ingredient for gout and hyperuricemia treatment, with EDMF regulatory data.
• Febuxostat G Antihyperuricemia active pharmaceutical ingredient variant for gout treatment, with EDMF regulatory data.
• Pirisudanol Dimaleate Active ingredient for cognitive impairment treatment, used in neurological and psychiatric applications, with EDMF regulatory data.
• Nitazoxanide Antiparasitic active pharmaceutical ingredient for treating parasitic infections.
• Silodosin Active pharmaceutical ingredient for treatment of prostatic hyperplasia, with EDMF regulatory data.
• L-Carnosine Nutraceutical active ingredient used in dietary supplement and food supplement formulations for the food industry.
• Sodium Bitartrate Anhydrous Excipient used as an auxiliary substance in pharmaceutical formulations.
• Contract Manufacturing Services (Active Ingredients) Contract manufacturing of active ingredients for pharmaceutical and food industries, ranging from manufacture of royalty-free products to novel products through bilateral agreements with customers.
• Custom Chemical Synthesis Bilateral agreement-based development and manufacture of novel chemical products for customers, using sophisticated technical equipment and plant facilities adapted to customer needs.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Gentec GroupcoreStrategic or Co-development PartnerParent company of Duke Chem. Duke Chem is a multipurpose plant of the Gentec Group, situated in the Barcelona area. Gentec Group is a Spanish industrial group with expertise in chemical manufacturing.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Hovione: Hovione is an Iberian-based (Portugal) contract API development and manufacturing organization (CDMO) serving the pharmaceutical industry with custom synthesis, particle engineering, and GMP manufacturing. It is the closest geographic and capability peer to Duke Chem's Barcelona-based multipurpose API plant.
• Fareva: Fareva is a French pharmaceutical contract manufacturer covering APIs, drug products, and cosmetics. Its API division competes directly with Duke Chem for European pharma custom manufacturing tenders, particularly for off-patent and complex small molecules.
• Carbogen Amcis: Carbogen Amcis (part of Dishman Carbogen Amcis) is a Swiss-based API CDMO offering process development, scale-up, and commercial manufacturing including high-potency APIs. Its service model and customer overlap with European pharma innovators closely mirrors Duke Chem's bilateral-agreement approach.
• Aenova: Aenova is a German-headquartered CDMO offering API manufacturing, solid dosage forms, and sterile fill-finish. Its API segment overlaps with Duke Chem's contract API offering to European pharmaceutical customers.
• Cambrex: Cambrex is a US-headquartered contract manufacturer of small-molecule APIs and intermediates with multiple GMP facilities across North America and Europe. It is comparable to Duke Chem in offering custom synthesis, commercial API supply, and regulatory support including DMFs/EDMFs for pharma customers.
• Curia (formerly AMRI): Curia is a global CDMO providing small-molecule API development and manufacturing, complex chemistry, and drug product services. It is comparable to Duke Chem in core contract API work though operating at meaningfully larger scale.
• Siegfried Holding: Siegfried is a Swiss-listed CDMO specializing in active pharmaceutical ingredients and intermediates with multiple manufacturing sites and a strong regulatory dossier library. Like Duke Chem, it offers both contract manufacturing and bilateral product development for innovator and generic pharma customers.

Broad incumbents

• Lonza Group: Lonza is the largest European-headquartered CDMO with a broad API, biologics, and cell-and-gene therapy portfolio. While its API segment overlaps with Duke Chem, Lonza operates as a broad incumbent serving pharma globally rather than specializing in Duke Chem's niche small-molecule custom manufacturing.
• WuXi STA (WuXi AppTec): WuXi STA is the contract API and drug product development arm of WuXi AppTec, one of the largest global CDMOs. It competes with Duke Chem on contract API manufacturing and custom synthesis at much larger scale, but it is a broad incumbent serving global pharma rather than a niche European specialist.

Emerging players

• Divi's Laboratories: Divi's Laboratories is a large Indian API manufacturer with strong positions in custom synthesis and generics. It competes with Duke Chem for the same generic and custom API molecules but at vastly greater scale, lower cost basis, and with broader customer reach — making it an emerging competitive threat rather than a niche peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/duke-chem

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Duke Chem